Wealth Enhancement Advisory Services, LLC Ocugen, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 17,083 shares of OCGN stock, worth $19,132. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,083
Previous 14,837
15.14%
Holding current value
$19,132
Previous $10,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding OCGN
# of Institutions
119Shares Held
75.3MCall Options Held
200KPut Options Held
151K-
Black Rock Inc. New York, NY17.9MShares$20.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.7MShares$18.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$7.72 Million0.0% of portfolio
-
State Street Corp Boston, MA5.93MShares$6.64 Million0.0% of portfolio
-
Ubs Group Ag4.37MShares$4.89 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $243M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...